Within the 4-week (Threat ratio 0.55, 95 CI 0.42?.71; p0.0001) and within the 8-week
Within the 4-week (Threat ratio 0.55, 95 CI 0.42?.71; p0.0001) and in the 8-week group (0.49, 0.37?.64; p0.0001) . Exacerbation reduction has been evaluated also in CALIMA study, together with…